Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 3272649, 9 pages
https://doi.org/10.1155/2017/3272649
Research Article

Study on the Inhibitory Effects of Ephedra Aconite Asarum Decoction on LPS-Induced Dendritic Cells

Beijing University of Chinese Medicine, Beijing 100029, China

Correspondence should be addressed to Min Liu; nc.ude.mcub@380996 and Qingguo Wang; moc.anis@8558gqgnaw

Received 3 July 2017; Revised 4 October 2017; Accepted 9 October 2017; Published 26 November 2017

Academic Editor: Juraj Majtan

Copyright © 2017 Wenting Ji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Hiroshima, K. Hsu, N. Tedla, S. Chow, N. Kawaguchi, and C. L. Geczy, “79: S100 proteins regulate LPS-induced inflammation in murine lung,” Cytokine, vol. 70, no. 1, pp. 46-47, 2014. View at Publisher · View at Google Scholar
  2. Z. Guo, Q. Li, Y. Han, Y. Liang, Z. Xu, and T. Ren, “Prevention of LPS-Induced acute lung injury in mice by progranulin,” Mediators of Inflammation, vol. 2012, Article ID 540794, pp. 1–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Wang, C. Allen, and M. Ballow, “Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-α from LPS-stimulated monocytes/macrophages,” Journal of Clinical Immunology, vol. 27, no. 2, pp. 193–200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. E. Macatonia, N. A. Hosken, M. Litton et al., “Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells,” The Journal of Immunology, vol. 154, no. 10, pp. 5071–5079, 1995. View at Google Scholar · View at Scopus
  5. S. Siegemund, N. Schütze, M. A. Freudenberg, M. B. Lutz, R. K. Straubinger, and G. Alber, “Production of IL-12, IL-23 and IL-27p28 by bone marrow-derived conventional dendritic cells rather than macrophages after LPS/TLR4-dependent induction by Salmonella Enteritidis,” Immunobiology, vol. 212, no. 9-10, pp. 739–750, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. D. Moudgil, “Interplay among cytokines and T cell subsets in the progression and control of immune-mediated diseases,” Cytokine, vol. 74, no. 1, pp. 1–4, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. M.-C. Rissoan, V. Soumelis, N. Kadowaki et al., “Reciprocal control of T helper cell and dendritic cell differentiation,” Science, vol. 283, no. 5405, pp. 1183–1186, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. R. M. Steinman, “The dendritic cell system and its role in immunogenicity,” Annual Review of Immunology, vol. 9, pp. 271–296, 1991. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Banchereau, F. Briere, C. Caux et al., “Immunobiology of dendritic cells,” Annual Review of Immunology, vol. 18, pp. 767–811, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. A. T. Prechtel and A. Steinkasserer, “CD83: an update on functions and prospects of the maturation marker of dendritic cells,” Archives of Dermatological Research, vol. 299, no. 2, pp. 59–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. F. J. Quintana, “Dendritic cells in autoimmunity, infections, and cancer,” Seminars in Immunopathology, vol. 39, no. 2, pp. 97-98, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. A. V. Villarino, Y. Kanno, J. R. Ferdinand, and J. J. O'Shea, “Mechanisms of Jak/STAT signaling in immunity and disease,” Journal of Immunology, vol. 194, no. 1, pp. 21–27, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. J. J. O'Shea, D. M. Schwartz, A. V. Villarino, M. Gadina, I. B. McInnes, and A. Laurence, “The JAK-STAT pathway: impact on human disease and therapeutic intervention,” Annual Review of Medicine, vol. 66, pp. 311–328, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Liu, Y. Pei, and Y. Hou, “Research progress of ephedra aconite asarum decoction,” Shandong Traditional Chinese Medicine, vol. 3, pp. 270–272, 2016. View at Google Scholar
  15. M. Liu, J. Yan, S. Guo et al., “Experience of Qinguo Wang on the use of ephedra aconite asarum decoction,” Chinese Journal of Traditional Chinese Medicine, vol. 53, no. 9, pp. 790-791, 2012. View at Google Scholar
  16. Y. Wen and Z. Liang, “Study on the literature of ephedra aconite asarum decoction,” Journal of Shaanxi College of Traditional Chinese Medicine, vol. 6, pp. 103–105, 2014. View at Google Scholar
  17. Z. Ma, Literatures and Experimental Study of Ephedra Aconite Asarum Decoction, Beijing University of Traditional Chinese Medicine, 2014.
  18. M. Chen, Z. Ma, and S. Zhang, “Current status of the use of ephedra aconite asarum decoction,” Journal of Liaoning University of Traditional Chinese Medicine, vol. 2, no. 4, pp. 5–9, 2013. View at Google Scholar
  19. Z. Zhan, “Treatment of 30 cases of allergic rhinitis by ephedra aconite asarum decoction,” Henan Traditional Chinese Medicine, vol. 31, no. 4, pp. 332-333, 2013. View at Google Scholar
  20. S. Zhang, P. Yang, C. Wang et al., “Discussion the use of ephedra aconite asarum decoction in the treatment of common cold based on ‘kidney deficiency and latent pathogen’ to explore ephedra aconite Asarum soup in the treatment of cold,” National Medicine Forum, vol. 30, no. 4, pp. 12-13, 2015. View at Google Scholar
  21. T. Ohhashi, “The ‘special cure’ for allergic rhinitis, ephedra aconite asarum decoction,” Chinese Medicine Research, vol. 13, no. 1, article 38, 1997, E. Chen (translator). View at Google Scholar
  22. Y. Li and J. Li, “Modified ephedra aconite asarum decoction with moxibustion for the treatment of 126 cases of allergic rhinitis,” World Chinese Medicine, vol. 9, no. 4, pp. 453–455, 2014. View at Google Scholar
  23. S. Wang, “Clinical observation on in the treatment of allergic rhinitis with ephedra aconite asarum decoction,” Shaanxi Traditional Chinese Medicine, vol. 36, no. 2, pp. 188-189, 2015. View at Google Scholar
  24. Z. Yang and N. Geng, “Ephedra aconite asarum decoction in the treatment of 70 cases of chronic arrhythmia,” Heilongjiang Traditional Chinese Medicine, vol. 44, no. 2, pp. 14-15, 2015. View at Google Scholar
  25. X. Yu, “Modified ephedra aconite asarum decoction combined with low-dose formoterol powder inhalation for the treatment of elderly patients with bronchial asthma,” Chinese Journal of Modern Drug Applications, vol. 7, no. 23, pp. 143-144, 2013. View at Google Scholar
  26. S. Dou, “Clinical application and current pharmacological research on ephedra aconite asarum decoction,” Medical Information, no. 7, article 378, 2014. View at Google Scholar
  27. W. Gao, Theory and Experimental Study on Ephedra Aconite Asarum Decoction, Beijing University of Traditional Chinese Medicine, 2008.
  28. F. Tang, S. Liang, F. Chen et al., “Study on the mechanisms of anti-inflammatory and immunosuppressive effects of ephedra aconite asarum decoction using integrated serum pharmacochemistry and serum pharmacology methods,” Chinese Journal of Traditional Chinese Medicine, vol. 40, no. 10, pp. 1971–1976, 2015. View at Google Scholar
  29. F. Cai, X. Tan, and F. Chen, “Effects of active ingredients of ephedra aconite asarum decoction on RAW264.7 cell viability,” Chinese Journal of Pharmacology and Clinics, vol. 5, pp. 8–11, 2013. View at Google Scholar
  30. K. Inaba, M. Inaba, N. Romani et al., “Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor,” The Journal of Experimental Medicine, vol. 176, no. 6, pp. 1693–1702, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Tian, Y. Deng, M. S. University et al., “Influence and significance of IL-4 on the expression of CD11c,CD80,CD86 on mouse bone marrow DC cells,” Chinese Journal of Clinicians, vol. 5, pp. 905–908, 2014. View at Google Scholar
  32. L. S. Van Rijt, N. Vos, M. Willart et al., “Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma,” The Journal of Allergy and Clinical Immunology, vol. 114, no. 1, pp. 166–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Aerts-Toegaert, C. Heirman, S. Tuyaerts et al., “CD83 expression on dendritic cells and T cells: correlation with effective immune responses,” European Journal of Immunology, vol. 37, no. 3, pp. 686–695, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Takeda, T. Tanaka, W. Shi et al., “Essential role of Stat6 in IL-4 signalling,” Nature, vol. 380, no. 6575, pp. 627–630, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Vento-Tormo, C. Company, J. Rodríguez-Ubreva et al., “IL-4 orchestrates STAT6-mediated DNA demethylation leading to dendritic cell differentiation,” Genome Biology, vol. 17, article 4, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Hupfer, J. Schick, K. Jozefowski, D. Voehringer, J. Ostrop, and R. Lang, “Stat6-dependent inhibition of mincle expression in mouse and human antigen-presenting cells by the Th2 cytokine IL-4,” Frontiers in Immunology, vol. 7, article 423, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. M. W. Lipscomb, L. Chen, J. L. Taylor et al., “Ectopic T-bet expression licenses dendritic cells for IL-12-independent priming of type 1 T cells in vitro,” Journal of Immunology, vol. 183, no. 11, pp. 7250–7258, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Yashiro, M. Kubo, H. Ogawa, K. Okumura, and C. Nishiyama, “PU.1 suppresses Th2 cytokine expression via silencing of GATA3 transcription in dendritic cells,” PLoS ONE, vol. 10, no. 9, Article ID e0137699, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. S. J. Szabo, S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher, “A novel transcription factor, T-bet, directs Th1 lineage commitment,” Cell, vol. 100, no. 6, pp. 655–669, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. W.-P. Zheng and R. A. Flavell, “The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells,” Cell, vol. 89, no. 4, pp. 587–596, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. D. C. Webb, Y. Cai, K. I. Matthaei, and P. S. Foster, “Comparative roles of IL-4, IL-13, and IL-4Rα in dendritic cell maturation and CD4+ Th2 cell function,” The Journal of Immunology, vol. 178, no. 1, pp. 219–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Blanco, A. K. Palucka, V. Pascual, and J. Banchereau, “Dendritic cells and cytokines in human inflammatory and autoimmune diseases,” Cytokine and Growth Factor Reviews, vol. 19, no. 1, pp. 41–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Q. Nhu, N. Cuesta, and S. N. Vogel, “Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2),” Journal of Endotoxin Research, vol. 12, no. 5, pp. 285–295, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. J. G. Bode, C. Ehlting, and D. Häussinger, “The macrophage response towards LPS and its control through the –STAT3 axis,” Cellular Signalling, vol. 24, no. 6, pp. 1185–1194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. A. H. Wagner, M. Conzelmann, F. Fitzer et al., “JAK1/STAT3 activation directly inhibits IL-12 production in dendritic cells by preventing CDK9/P-TEFb recruitment to the p35 promoter,” Biochemical Pharmacology, vol. 96, no. 1, pp. 52–64, 2015. View at Publisher · View at Google Scholar
  46. A. A. te Velde, Y. van Kooyk, H. Braat et al., “Increased expression of DC-SIGN+IL-12+IL-18+ and CD83+IL-12IL-18 dendritic cell populations in the colonic mucosa of patients with Crohn's disease,” European Journal of Immunology, vol. 33, no. 1, pp. 143–151, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Nakayama, K. Hirahara, A. Onodera et al., “Th2 cells in health and disease,” Annual Review of Immunology, vol. 35, no. 1, pp. 53–84, 2017. View at Publisher · View at Google Scholar